Updated review of CRF-1 receptor antagonist development for anxiety and depression, covering new compounds, clinical trial results, and reasons for mixed success — the continuing quest for stress peptide drugs.
Key findingUpdated review of CRF-1 receptor antagonist development for anxiety and depression, covering new compounds, clinical trial results, and reasons for mi
What the researchers found
Updated review of CRF-1 receptor antagonist development for anxiety and depression, covering new compounds, clinical trial results, and reasons for mixed success — the continuing quest for stress peptide drugs.
Why it matters
Relevant for peptide research.
How the study worked
research study.
What this study cannot tell us
See abstract.
How to read the evidence
emerging evidence.
When this study was published
Published in 2010.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
Common questions
What was studied?
What was found?
Read the original research
Progress in corticotropin-releasing factor-1 antagonist development.
Drug discovery today, 15(9-10), 371-83
Citation
Zorrilla, Eric P; Koob, George F. (2010). Progress in corticotropin-releasing factor-1 antagonist development.. Drug discovery today, 15(9-10), 371-83. https://doi.org/10.1016/j.drudis.2010.02.011